Intervention of Nicotinamide Mononucleotide in Middle-aged and Elderly People

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Aging, NMN

In brief

This study is a single-center, randomized, double-blind, placebo-controlled clinical trial investigating a pharmacological intervention for aging. Its primary objective is to evaluate the efficacy of NMN while ensuring the safety of oral administration, with the aim of identifying effective strategies to delay aging and improve the quality of life in the elderly population. The main outcomes of this study are to characterize the patterns of NMN efficacy across different populations and to identify sensitive biomarkers that reflect responsiveness to the intervention.

Key facts

Study ID
NCT06592859
Run by
People's Hospital of Quzhou
People needed
240
Starts
2023-08-23
Expected to finish
2026-12-31
Last updated by the study team
2026-05-08

Who can join

Age: 39 and older, up to 70. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.